tiprankstipranks
Trending News
More News >

Fusen Pharmaceutical Announces Change in Shareholding Structure

Story Highlights
  • Fusen Pharmaceutical’s shareholding structure changes after Mr. Cao’s passing.
  • Mr. Cao Zhiming’s voting rights increase to 45.29%, waiver obtained for mandatory offer.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Fusen Pharmaceutical Announces Change in Shareholding Structure

Don’t Miss TipRanks’ Half-Year Sale

Fusen Pharmaceutical Co., Ltd. ( (HK:1652) ) has provided an announcement.

Fusen Pharmaceutical Co., Ltd. has announced a significant change in its shareholding structure following the passing of Mr. Cao, the former chairman and investment manager of Fusen Trust. The Vesting Arrangement has transferred control of the voting rights of Fusen Trust Shares to Mr. Cao Zhiming, increasing his voting rights to 45.29% of the total issued shares. This change has triggered a potential requirement for a mandatory general offer under the Takeovers Code, but Mr. Cao Zhiming has obtained a waiver from this obligation.

More about Fusen Pharmaceutical Co., Ltd.

Average Trading Volume: 352,155

Technical Sentiment Signal: Sell

Current Market Cap: HK$286.7M

See more insights into 1652 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1